ELI LILLY & Co
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Cardiovascular therapeutic area by Year
Cardiovascular therapeutic area — Worldwide revenue ($M) [legacy grouping through FY2018] ($M)
Eli Lilly Cardiovascular therapeutic area: $2,871M in FY2017, down 11.0% from a year earlier. No newer figure appears in the documents we track.
Where the FY2017 figure comes from
Source: Form 10-K (filed 2018-02-20) ↗
Reported in Form 10-K Segment & Disaggregated Revenue Note (legacy Cardiovascular grouping).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cardiovascular therapeutic area — Worldwide revenue ($M) [legacy grouping through FY2018] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2017 | Dec 31, 2017 | 2,871 | -11.0% | Form 10-K (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | 3,225 | +5.1% | Form 10-K (filed 2018-02-20) ↗ |
| FY2015 | Dec 31, 2015 | 3,068 | +0.5% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 3,054 | +4.5% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 2,923 | +11.0% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 2,633 | +5.9% | Form 10-K (filed 2014-02-19) ↗ |
| FY2011 | Dec 31, 2011 | 2,486 | – | Form 10-K (filed 2014-02-19) ↗ |
Breakdown
What makes up cardiovascular therapeutic area
Cite this data
StockData. (2026). Eli Lilly Cardiovascular therapeutic area ($M), annual FY2011–FY2017 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/ta-cardiovascular-ww-legacy
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.